NAKU
LIVE

Serial Number

99889749

Owner

Ferring B.V.

Attorney

Joyce M. Ferraro

Filing Date

Jun 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NAKU Trademark

Serial Number: 99889749

NAKU is a trademark filed by Ferring B.V. on June 17, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Ferring B.V. (5 trademarks)

Polarisavenue 144
Hoofddorp NL-2132JX , NL

Entity Type: 16

Trademark Details

Filing Date

June 17, 2026

Registration Date

Not Registered

Goods & Services

Biological preparations for use in the pharmaceutical industry; biological preparations for scientific and research use; biological cell preparations for use in the pharmaceutical industry and for laboratory and scientific use; T-cells and gamma delta T-cells for use in the pharmaceutical industry and for laboratory and scientific use; cell cultures for use in the pharmaceutical industry and for laboratory and scientific use; biological materials for use in cellular engineering; biological materials for use in immunology research; cellular starting materials for use in the pharmaceutical industry and for laboratory and scientific use; biological preparations for use in the development of cellular therapies; biological materials for use in pharmaceutical and biomedical research

Pharmaceutical and biological preparations for medical and therapeutic use; cellular preparations for medical and therapeutic use; T-cells and gamma delta T-cells for medical and therapeutic use; genetically engineered cellular preparations for medical and therapeutic use; engineered immune cell preparations for medical and therapeutic purposes; biological preparations for use in cellular therapy; cell-based therapeutic preparations; cellular therapeutic preparations for the treatment of cancer, infectious diseases and immune-related disorders

Pharmaceutical and biomedical research and development services; scientific research and development in the field of biotechnology, immunology, cell therapy, immunotherapy and regenerative medicine; scientific research relating to immune cells, T-cells, gamma delta T-cells, adoptive cell therapies and cancer therapies; laboratory research relating to cellular and genetic engineering; development of engineered immune cells and cellular therapeutic products for therapeutic applications; laboratory services relating to biotechnology and cellular manipulation; clinical research services; scientific consultancy relating to biotechnology, immunotherapy and pharmaceutical development; providing scientific information relating to cellular therapies and immunotherapeutics

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 17, 2026 MAFR
NEW APPLICATION ENTERED
Jun 17, 2026 NWAP